News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,147 signal articles · 105 in last 24h · 178,672 total before filter · latest 42m ago

105last 24h

3127last 7d

510● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1820 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: HALOsentiment: neutralSentiment:bullish neutral bearish show all (incl. clickbait)

Simply Wall St.2d agoneutral

Halozyme Therapeutics (HALO) Following Record Results And Higher Guidance Is The Stock Still Undervalued

HALO MRK

GuruFocus.com2d agoneutral

Halozyme Stocks Slip 4.28% Despite 39% Revenue Growth and Modestly Higher Guidance

HALO

MT Newswires2d agoneutral

Halozyme Says US FDA Approves Rybrevant Faspro Co-Formulated With Enhanze to Treat Head, Neck Cancer

HALO JNJ

PR Newswire2d agoneutral

U.S. FDA Approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Co-Formulated with Halozyme's ENHANZE® Technology for the Treatment of Advanced Head and Neck Cancer

HALO JNJ

Zacks2d agoneutral

HALO Q3 Earnings Call Highlights Royalty Growth and Patent Dispute

HALO MRK

Motley Fool2d agoneutral

Halozyme (HALO) Q3 2026 Earnings Call Transcript

HALO

GuruFocus.com2d agoneutral

Halozyme Therapeutics Inc (HALO) (Q3 2026) Earnings Call Highlights: Record Revenue, Raised ...

HALO MRK

MarketBeat2d agoneutral

What Halozyme Therapeutics (HALO) Said on Its Q3 Earnings Call

BMY HALO MRK

Zacks3d agoneutral

Compared to Estimates, Halozyme Therapeutics (HALO) Q3 Earnings: A Look at Key Metrics

HALO

MT Newswires3d agoneutral

Halozyme Therapeutics Q3 Adjusted Earnings, Revenue Rise; 2026 Guidance Lifted

HALO

Associated Press3d agoneutral

Halozyme Therapeutics: Q3 Earnings Snapshot

HALO

PR Newswire3d agoneutral

HALOZYME REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE

HALO

Zacks4d agoneutral

Halozyme Therapeutics (HALO) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

HALO

Zacks10d agoneutral

Halozyme Therapeutics (HALO) Reports Next Week: Wall Street Expects Earnings Growth

HALO

Investor's Business Daily72d agoneutral

Tight Action In HALO Stock Sets Up Heavenly Gains

HALO

Motley Fool87d agoneutral

Halozyme (HALO) Q2 2026 Earnings Call Transcript

HALO

GuruFocus.com93d agoneutral

Halozyme Therapeutics Inc (HALO) (Q2 2026) Earnings Call Highlights: Record Revenue and Royalty ...

HALO

Moby93d agoneutral

Halozyme Therapeutics, Inc. Q2 2026 Earnings Call Summary

HALO

MarketBeat94d agoneutral

Halozyme Therapeutics Q2 Earnings Call Highlights

HALO

Zacks94d agoneutral

Compared to Estimates, Halozyme Therapeutics (HALO) Q2 Earnings: A Look at Key Metrics

HALO

Zacks94d agoneutral

Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

HALO

Investor's Business Daily107d agoneutral

Four Stocks Hit New Highs Amid Tech Meltdown

HALO PM

Zacks151d agoneutral

Halozyme Therapeutics (HALO) Up 0.8% Since Last Earnings Report: Can It Continue?

HALO

StockStory179d agoneutral

Halozyme Therapeutics Earnings: What To Look For From HALO

HALO

GuruFocus.com180d agoneutral

Halozyme Therapeutics Inc (HALO) Q1 2026 Earnings Call Highlights: Record Revenue Growth and ...

HALO

MarketBeat181d agoneutral

Halozyme Therapeutics Q1 Earnings Call Highlights

HALO

Zacks181d agoneutral

Halozyme Therapeutics (HALO) Reports Q1 Earnings: What Key Metrics Have to Say

HALO

Zacks181d agoneutral

Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates

HALO

Zacks186d agoneutral

Halozyme Therapeutics (HALO) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

HALO

MarketBeat187d agoneutral

Halozyme Therapeutics AGM: Shareholders Elect Directors as CEO Torley Raises 2026 Guidance

HALO